TY  - RPRT
TI  - Rapamycin, an Immunosuppressant and mTORC1 Inhibitor, Triples the antidepressant Response Rate of Ketamine at 2 Weeks Following Treatment: A double-blind, placebo-controlled, cross-over, randomized clinical trial
AU  - Abdallah, C.
AU  - Averill, L. A.
AU  - Gueorguieva, R.
AU  - Goktas, S.
AU  - Purohit, P.
AU  - Ranganathan, M.
AU  - D'Souza, D. C.
AU  - Formica, R.
AU  - Southwick, S. M.
AU  - Duman, R. S.
AU  - Sanacora, G.
AU  - Krystal, J.
PY  - 2018
DO  - 10.1101/500959
UR  - https://www.biorxiv.org/content/10.1101/500959v1
ID  - 10.1101/500959
ER  -